These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 35266425)

  • 1. Boosting curcumin activity against human prostatic cancer PC3 cells by utilizing scorpion venom conjugated phytosomes as promising functionalized nanovesicles.
    Al-Rabia MW; Alhakamy NA; Rizg WY; Alghaith AF; Ahmed OAA; Fahmy UA
    Drug Deliv; 2022 Dec; 29(1):807-820. PubMed ID: 35266425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phyto-Phospholipid Conjugated Scorpion Venom Nanovesicles as Promising Carrier That Improves Efficacy of Thymoquinone against Adenocarcinoma Human Alveolar Basal Epithelial Cells.
    Asfour HZ; Fahmy UA; Alharbi WS; Almehmady AM; Alamoudi AJ; Tima S; Mansouri RA; Omar UM; Ahmed OAA; Zakai SA; Aldarmahi AA; Bagalagel A; Diri R; Alhakamy NA
    Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scorpion Venom-Functionalized Quercetin Phytosomes for Breast Cancer Management: In Vitro Response Surface Optimization and Anticancer Activity against MCF-7 Cells.
    Alhakamy NA; Fahmy UA; Eldin SMB; Ahmed OAA; Aldawsari HM; Okbazghi SZ; Alfaleh MA; Abdulaal WH; Alamoudi AJ; Mady FM
    Polymers (Basel); 2021 Dec; 14(1):. PubMed ID: 35012116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-proliferative and apoptotic effect of gemini curcumin in p53-wild type and p53-mutant colorectal cancer cell lines.
    Ebrahimi M; Babaei E; Neri F; Feizi MAH
    Int J Pharm; 2021 May; 601():120592. PubMed ID: 33857585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RGD-decorated nanoliposomes for combined delivery of arsenic trioxide and curcumin to prostate cancer cells.
    Khosravani F; Amiri F; Mahmoudi R; Morshedi D; Kobarfard F; Alipour M; Hosseini E; Bardania H
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2347-2357. PubMed ID: 37831114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation of curcumin delivery with functionalized single-walled carbon nanotubes: characteristics and anticancer effects in vitro.
    Li H; Zhang N; Hao Y; Wang Y; Jia S; Zhang H; Zhang Y; Zhang Z
    Drug Deliv; 2014 Aug; 21(5):379-87. PubMed ID: 24160816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of curcumin-loaded gemini surfactant nanoparticles: Synthesis, characterization and evaluation of anticancer activity against human breast cancer cell lines.
    Karimpour M; Feizi MAH; Mahdavi M; Krammer B; Verwanger T; Najafi F; Babaei E
    Phytomedicine; 2019 Apr; 57():183-190. PubMed ID: 30776589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer.
    Yallapu MM; Khan S; Maher DM; Ebeling MC; Sundram V; Chauhan N; Ganju A; Balakrishna S; Gupta BK; Zafar N; Jaggi M; Chauhan SC
    Biomaterials; 2014 Oct; 35(30):8635-48. PubMed ID: 25028336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo.
    Yan J; Wang Y; Zhang X; Liu S; Tian C; Wang H
    Drug Deliv; 2016 Jun; 23(5):1757-62. PubMed ID: 26203689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The scorpion venom peptide BmKn2 induces apoptosis in cancerous but not in normal human oral cells.
    Satitmanwiwat S; Changsangfa C; Khanuengthong A; Promthep K; Roytrakul S; Arpornsuwan T; Saikhun K; Sritanaudomchai H
    Biomed Pharmacother; 2016 Dec; 84():1042-1050. PubMed ID: 27780132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colon Targeted Eudragit Coated Beads Loaded with Optimized Fluvastatin-Scorpion Venom Conjugate as a Potential Approach for Colon Cancer Therapy: In Vitro Anticancer Activity and In Vivo Colon Imaging.
    Ahmed OAA; Badr-Eldin SM; Caruso G; Fahmy UA; Alharbi WS; Almehmady AM; Alghamdi SA; Alhakamy NA; Mohamed AI; Aldawsari HM; Mady FM
    J Pharm Sci; 2022 Dec; 111(12):3304-3317. PubMed ID: 36007556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted nanogel conjugate for improved stability and cellular permeability of curcumin: synthesis, pharmacokinetics, and tumor growth inhibition.
    Wei X; Senanayake TH; Bohling A; Vinogradov SV
    Mol Pharm; 2014 Sep; 11(9):3112-22. PubMed ID: 25072100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pH-sensitive delivery system based on N-succinyl chitosan-ZnO nanoparticles for improving antibacterial and anticancer activities of curcumin.
    Ghaffari SB; Sarrafzadeh MH; Salami M; Khorramizadeh MR
    Int J Biol Macromol; 2020 May; 151():428-440. PubMed ID: 32068061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human prostate cancer cell epithelial-to-mesenchymal transition as a novel target of arsenic trioxide and curcumin therapeutic approach.
    Mirzaei A; Jahanshahi F; Khatami F; Reis LO; Aghamir SMK
    Tissue Cell; 2022 Jun; 76():101805. PubMed ID: 35487055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination index and glycoproteomics-based approach revealed synergistic anticancer effects of curcuminoids of turmeric against prostate cancer PC3 cells.
    Wei MM; Zhao SJ; Dong XM; Wang YJ; Fang C; Wu P; Song GQ; Gao JN; Huang ZH; Xie T; Zhou JL
    J Ethnopharmacol; 2021 Mar; 267():113467. PubMed ID: 33058923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular uptake and apoptotic properties of gemini curcumin in gastric cancer cells.
    Emami A; Babaei E; Nagishbandi A; Azeez HJ; Feizi MAH; Golizadeh A
    Mol Biol Rep; 2021 Nov; 48(11):7215-7222. PubMed ID: 34623595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
    Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
    Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanostructured lipid carriers enhance the bioavailability and brain cancer inhibitory efficacy of curcumin both in vitro and in vivo.
    Chen Y; Pan L; Jiang M; Li D; Jin L
    Drug Deliv; 2016 May; 23(4):1383-92. PubMed ID: 26066035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecule tolfenamic acid and dietary spice curcumin treatment enhances antiproliferative effect in pancreatic cancer cells via suppressing Sp1, disrupting NF-kB translocation to nucleus and cell cycle phase distribution.
    Basha R; Connelly SF; Sankpal UT; Nagaraju GP; Patel H; Vishwanatha JK; Shelake S; Tabor-Simecka L; Shoji M; Simecka JW; El-Rayes B
    J Nutr Biochem; 2016 May; 31():77-87. PubMed ID: 27133426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway.
    Deeb D; Jiang H; Gao X; Al-Holou S; Danyluk AL; Dulchavsky SA; Gautam SC
    J Pharmacol Exp Ther; 2007 May; 321(2):616-25. PubMed ID: 17289836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.